GE Healthcare's (GE -0.6%) Clarient Diagnostic Services announces the first lab developed test...
GE Healthcare's (GE -0.6%) Clarient Diagnostic Services announces the first lab developed test using MultiOmyx, a new pathology platform which uses proprietary methodology to assess multiple proteins from a single tissue section at a single-cell level. This test will assist in pathologist’s diagnosis of CD30-positive lymphoma cases with difficult morphology or otherwise insufficient tissue to adequately evaluate the case.
From other sites
Video at CNBC.com (Tue, 11:02AM)
Video at CNBC.com (Aug 19, 2015)
Video at CNBC.com (Aug 18, 2015)
Video at CNBC.com (Aug 17, 2015)
Video at CNBC.com (Aug 5, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs